Promotion of indigenous pharmaceutical manufacturing
PLI scheme for Bulk Drugs has a total budgetary outlay of Rs. 6,940 crore
PLI scheme for Bulk Drugs has a total budgetary outlay of Rs. 6,940 crore
States exhorted to ensure rational use of cough syrups, particularly among children, as most coughs are self-limiting and do not require pharmacological treatment
The three-day expo will feature an expansive exhibition showcasing MSMEs, startups, research institutions, future innovation pavilions, state showcases, and government initiatives
The company has received final approval from the Department of Pharmaceuticals, Government of India, for foreign investment under applicable regulations
Lays foundation stone of NIPER Hyderabad and NIPER Raebareli
Lack of technology transfer stands out as a formidable barrier
The aggregate foreign investment, including investment from other foreign investors may be up to 90.1% shareholding in the company
With India supplying around 60% of the world's vaccine needs and 20-22% of generic exports, the country is dedicated to providing affordable, high-quality drugs and contribute to global accessibility
Dr. Mandaviya urged the stakeholders to capitalize on the current opportunities
Subscribe To Our Newsletter & Stay Updated